T vs. ABBV
T (AT&T Inc.) and ABBV (AbbVie Inc.) are both stocks. T operates in Telecom Services (Communication Services), while ABBV operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, T returned 2.86%/yr vs 18.63%/yr for ABBV. At a 0.28 correlation, their price movements are largely independent.
Performance
T vs. ABBV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, T achieves a -7.40% return, which is significantly lower than ABBV's -0.77% return. Over the past 10 years, T has underperformed ABBV with an annualized return of 2.86%, while ABBV has yielded a comparatively higher 18.63% annualized return.
T
- 1D
- -1.10%
- 1M
- -10.57%
- YTD
- -7.40%
- 6M
- -7.40%
- 1Y
- -16.38%
- 3Y*
- 18.39%
- 5Y*
- 6.60%
- 10Y*
- 2.86%
ABBV
- 1D
- -1.83%
- 1M
- 10.68%
- YTD
- -0.77%
- 6M
- 1.62%
- 1Y
- 21.34%
- 3Y*
- 21.59%
- 5Y*
- 18.74%
- 10Y*
- 18.63%
T vs. ABBV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
T AT&T Inc. | -7.40% | 13.97% | 44.08% | -2.74% | 5.76% | -8.09% | -21.37% | 45.55% | -22.25% | -4.01% |
ABBV AbbVie Inc. | -0.77% | 33.08% | 18.86% | -0.23% | 24.01% | 32.43% | 27.72% | 1.47% | -0.96% | 60.07% |
Correlation
The correlation between T and ABBV is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Jan 3, 2013 | 0.28 |
The correlation between T and ABBV shifts across timeframes, from 0.17 (1 year) to 0.28 (all time), reflecting how their relationship changes across market environments.
Fundamentals
T:
$3.04
ABBV:
$2.05
T:
7.39
ABBV:
108.68
T:
1.29
ABBV:
6.30
T:
$125.65B
ABBV:
$62.82B
T:
$105.41B
ABBV:
$46.15B
T:
$54.70B
ABBV:
$17.96B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
T vs. ABBV — Risk / Return Rank
T
ABBV
T vs. ABBV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AT&T Inc. (T) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| T | ABBV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.63 | ||
| Sortino ratioReturn per unit of downside risk | -2.35 | ||
| Omega ratioGain probability vs. loss probability | 0.89 | 1.17 | -0.29 |
| Calmar ratioReturn relative to maximum drawdown | -0.75 | 1.24 | -1.99 |
| Martin ratioReturn relative to average drawdown | -1.59 | 2.77 | -4.36 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| T | ABBV | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.75 | 0.88 | -1.63 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.28 | 0.82 | -0.55 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.12 | 0.73 | -0.61 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.38 | 0.74 | -0.36 |
Drawdowns
T vs. ABBV - Drawdown Comparison
The maximum T drawdown since its inception was -64.15%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for T and ABBV.
Loading charts...
Drawdown Indicators
| T | ABBV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -64.15% | -45.09% | -19.06% |
Max Drawdown (1Y)Largest decline over 1 year | -21.87% | -17.32% | -4.55% |
Max Drawdown (3Y)Largest decline over 3 years | -21.87% | -20.74% | -1.13% |
Max Drawdown (5Y)Largest decline over 5 years | -32.01% | -21.92% | -10.09% |
Max Drawdown (10Y)Largest decline over 10 years | -42.35% | -45.09% | +2.74% |
Current DrawdownCurrent decline from peak | -21.87% | -6.55% | -15.32% |
Average DrawdownAverage peak-to-trough decline | -15.72% | -10.72% | -5.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.34% | 7.72% | +2.62% |
Volatility
T vs. ABBV - Volatility Comparison
AT&T Inc. (T) has a higher volatility of 7.50% compared to AbbVie Inc. (ABBV) at 6.39%. This indicates that T's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| T | ABBV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.50% | 6.39% | +1.11% |
Volatility (6M)Calculated over the trailing 6-month period | 17.57% | 17.89% | -0.32% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.98% | 24.33% | -2.35% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.97% | 22.91% | +1.06% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.71% | 25.74% | -2.03% |
Dividends
T vs. ABBV - Dividend Comparison
T's dividend yield for the trailing twelve months is around 4.93%, more than ABBV's 3.02% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 3.02% | 2.87% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% |
T AT&T Inc. | 4.93% | 4.47% | 4.87% | 6.62% | 6.66% | 8.46% | 7.23% | 5.22% | 7.01% | 5.04% | 4.51% | 5.46% |
Financials
T vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between AT&T Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
T and ABBV have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
T has higher volatility (7.50%) compared to ABBV (6.39%). In terms of maximum drawdown, T dropped -64.15% vs ABBV's -45.09%.
ABBV currently has the higher Sharpe Ratio (0.88 vs -0.75), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for T and ABBV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer